DFE Pharma, Harro Höfliger and Sterling Partner to Provide Respiratory Product Formulation Services


DFE Pharma, Harro Höfliger and Sterling announced a partnership called Inhalation Together to provide respiratory product formulation services.

Excipient solutions provider DFE Pharma, equipment manufacturer Harro Höfliger and API manufacturer Sterling announced on March 24, 2022 a unique partnership with the creation of Inhalation Together (INTO) in the field of powder inhalation dry (DPI).

This initiative will provide R&D services to pharmaceutical companies in the respiratory field, improving formulation development to be simpler, faster and more manageable. The combination of INTO’s suite of services and each of the companies’ areas of expertise enables a stronger and more focused progression for development.

The development of a DPI formulation requires a strong interdependence between the process, the powder, the device and the patient. To deal with this complexity, INTO provides consulting services, such as solid state characterization and sonocrystallization of APIs and studies to optimize formulation, mixing and filling.

I am very excited about the INTO initiative as it speeds time to market and reduces complexity in formulation and process development,” said Martti Hedman, CEO of DFE Pharma, in the press release. “All three companies have a very good understanding of the critical aspects of developing and manufacturing DPI products, adding significant value to our customers.”

Source: DFE Pharma


Comments are closed.